p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells
Ori Hassin(Weizmann Institute of Science), Moshe Oren(Weizmann Institute of Science), Ruth Scherz‐Shouval(Weizmann Institute of Science), Tomer‐Meir Salame(Weizmann Institute of Science), Max D. Wellenstein(The Netherlands Cancer Institute), Felix C. E. Vogel(German Cancer Research Center), Tamar Geiger(Weizmann Institute of Science), Karin E. de Visser(The Netherlands Cancer Institute), Lisa Schlicker(German Cancer Research Center), Coral Halperin(Weizmann Institute of Science), Adi Seligman(Weizmann Institute of Science), Almut Schulze(German Cancer Research Center), Avital Sarusi-Portuguez, Joachim Smollich(Weizmann Institute of Science), Miriam Sernik(Weizmann Institute of Science), Yael Aylon(Weizmann Institute of Science), Liron Nomi Toledano(Weizmann Institute of Science), Anna Chiara Pirona(Weizmann Institute of Science)
Cited by 12
Related Papers
The Perseus computational platform for comprehensive analysis of (prote)omics data
|Nature Methods|2016|8.9k
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
|Nature|2015|1.7k
Lipid metabolism in cancer
|FEBS Journal|2012|1.3k
Decision making by p53: life, death and cancer
|Cell Death and Differentiation|2003|1.1k
Comparative Proteomic Analysis of Eleven Common Cell Lines Reveals Ubiquitous but Varying Expression of Most Proteins
|Molecular & Cellular Proteomics|2012|845